Fang Li

机构：Ningbo University, Ningbo University Affiliated Hospital, Ningbo First Hospital · ORCID：0000-0002-7551-5899

发表论文 128 篇 · 总被引 1133 次 · h-index 19

代表论文

• US Food and Drug Administration Approval Summary: Elacestrant for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, ESR1 -Mutated Advanced or Metastatic Breast Cancer (2024 · Journal of Clinical Oncology · 被引 43)
• Spatiotemporal analyses of the pan-cancer single-cell landscape reveal widespread profibrotic ecotypes associated with tumor immunity (2025 · Nature Cancer · 被引 21)
• SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma (2024 · International Journal of Biological Sciences · 被引 10)
• The impact of high-sugar diets on central nervous system disorders: mechanisms, pathogenesis, and dietary implication (2025 · Annals of Medicine · 被引 9)
• Head-to-Head Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for the Assessment of Crohn’s Disease (2025 · Clinical Nuclear Medicine · 被引 9)
• FGR-associated placental insufficiency and capillary angiogenesis involves disruptions in human placental miRNAs and mRNAs (2024 · Heliyon · 被引 8)